$2.23T
Total marketcap
$74.76B
Total volume
BTC 56.21%     ETH 9.01%
Dominance
us

Bio-Rad Laboratories, Inc. BIO-B Stock

$290.00   -4.652310%
Add to favorites
Exchange
Market Cap
$7.76B
LOW - HIGH [24H]
$290.00 - $290.00
VOLUME [24H]
$818.00
P/E Ratio
48.17
Earnings per share
$6.02
Price   Prediction

Bio-Rad Laboratories, Inc. Price Chart

Sorry, that's all we've gotfor now...

Bio-Rad Laboratories, Inc. BIO-B Financial and Trading Overview

Bio-Rad Laboratories, Inc. stock price 290 USD
Previous Close 304.15 USD
Open 304.15 USD
Bid 293.17 USD x 8000
Ask 299.97 USD x 4000
Day's Range 304.15 - 304.15 USD
52 Week Range 244.54 - 321.12 USD
Volume 11 USD
Avg. Volume 96 USD
Market Cap 8.14B USD
Beta (5Y Monthly) 1.08
PE Ratio (TTM) 50.523254
EPS (TTM) 6.02 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BIO-B Valuation Measures

Enterprise Value 7.95B USD
Trailing P/E 50.523254
Forward P/E N/A
PEG Ratio (5 yr expected) 4.23
Price/Sales (ttm) 3.1428008
Price/Book (mrq) 1.1909983
Enterprise Value/Revenue 3.071
Enterprise Value/EBITDA 17.88

Trading Information

Bio-Rad Laboratories, Inc. Stock Price History

Beta (5Y Monthly) 1.08
52-Week Change 21.62%
S&P500 52-Week Change 24.48%
52 Week High 321.12 USD
52 Week Low 244.54 USD
50-Day Moving Average 285.74 USD
200-Day Moving Average 289.72 USD

BIO-B Share Statistics

Avg. Volume (3 month) 96 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 5.06M
Float 20.91M
Short Ratio 0.16
% Held by Insiders 98.22%
% Held by Institutions 0.077%
Shares Short 14
Short % of Float 0.010%
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 6.51%
Operating Margin (ttm) 5.75%
Gross Margin 52.00%
EBITDA Margin 17.17%

Management Effectiveness

Return on Assets (ttm) 1.79%
Return on Equity (ttm) 2.49%

Income Statement

Revenue (ttm) 2.59B USD
Revenue Per Share (ttm) 95.8 USD
Quarterly Revenue Growth (yoy) 1.09%
Gross Profit (ttm) 1.35B USD
EBITDA 444.8M USD
Net Income Avi to Common (ttm) 168.8M USD
Diluted EPS (ttm) 6.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.56B USD
Total Cash Per Share (mrq) 58.47 USD
Total Debt (mrq) 1.38B USD
Total Debt/Equity (mrq) 20.12 USD
Current Ratio (mrq) 3.208
Book Value Per Share (mrq) 255.374

Cash Flow Statement

Operating Cash Flow (ttm) 510.4M USD
Levered Free Cash Flow (ttm) 229.76M USD

Profile of Bio-Rad Laboratories, Inc.

Country United States
State CA
City Hercules
Address 1000 Alfred Nobel Drive
ZIP 94547
Phone 510 724 7000
Website https://www.bio-rad.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 7450

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Q&A For Bio-Rad Laboratories, Inc. Stock

What is a current BIO-B stock price?

Bio-Rad Laboratories, Inc. BIO-B stock price today per share is 290 USD.

How to purchase Bio-Rad Laboratories, Inc. stock?

You can buy BIO-B shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio-Rad Laboratories, Inc.?

The stock symbol or ticker of Bio-Rad Laboratories, Inc. is BIO-B.

Which industry does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. industry is Medical Devices.

How many shares does Bio-Rad Laboratories, Inc. have in circulation?

The max supply of Bio-Rad Laboratories, Inc. shares is 26.76M.

What is Bio-Rad Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?

Bio-Rad Laboratories, Inc. PE Ratio is 48.17275600 now.

What was Bio-Rad Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?

Bio-Rad Laboratories, Inc. EPS is 6.02 USD over the trailing 12 months.

Which sector does the Bio-Rad Laboratories, Inc. company belong to?

The Bio-Rad Laboratories, Inc. sector is Healthcare.

Bio-Rad Laboratories, Inc. BIO-B included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us NYSE Composite Index NYA US 23463.63 USD
-0.56
23332.58 USD 23596.22 USD
Select currency